Diagnosis and treatment of eosinophilic esophagitis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31910983.
- Also identified by DOI 10.1016/j.jaci.2019.11.011 and PMC identifier 6986782.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Eosinophilic esophagitis (EoE) is an eosinophil-rich, T<sub>H</sub>2 antigen-mediated disease of increasing pediatric and adult worldwide prevalence. Diagnosis requires greater than or equal to 15 eosinophils per high-power field on light microscopy. Symptoms reflect esophageal dysfunction, and typical endoscopic features include linear furrows, white plaques, and concentric rings. Progressive disease leads to pathologic tissue remodeling, with ensuing esophageal rigidity and loss of luminal diameter caused by strictures. Therapies include proton pump inhibitors, elimination diets, and topical corticosteroids. Effective treatment can reverse tissue fibrosis in some patients, as well as decrease the rate of food impactions. Esophageal dilation might be required to increase luminal patency. The chronic nature of EoE necessitates long-term therapy to avoid disease recurrence and complications. This review serves the function of providing the current state-of-the-art diagnostic criteria and disease management for adult and pediatric EoE.
Medical subject headings
- Adrenal Cortex Hormones
- Diet Therapy
- Eosinophilic Esophagitis
- Proton Pump Inhibitors